IL114697A0 - Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use - Google Patents
Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and useInfo
- Publication number
- IL114697A0 IL114697A0 IL11469795A IL11469795A IL114697A0 IL 114697 A0 IL114697 A0 IL 114697A0 IL 11469795 A IL11469795 A IL 11469795A IL 11469795 A IL11469795 A IL 11469795A IL 114697 A0 IL114697 A0 IL 114697A0
- Authority
- IL
- Israel
- Prior art keywords
- ubiquitin
- polypeptides
- preparation
- fusion protein
- protein products
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8239—Externally regulated expression systems pathogen inducible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27947294A | 1994-07-22 | 1994-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL114697A0 true IL114697A0 (en) | 1995-11-27 |
Family
ID=23069116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11469795A IL114697A0 (en) | 1994-07-22 | 1995-07-23 | Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use |
Country Status (7)
Country | Link |
---|---|
US (1) | US6448391B1 (fr) |
EP (1) | EP0781347A4 (fr) |
JP (1) | JPH10507069A (fr) |
AU (2) | AU3199695A (fr) |
CA (1) | CA2195625C (fr) |
IL (1) | IL114697A0 (fr) |
WO (2) | WO1996003522A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0932413A1 (fr) | 1996-10-04 | 1999-08-04 | Demegen, Inc. | Procede de traitement d'une contamination par le virus de l'immunodeficience |
US6121436A (en) | 1996-12-13 | 2000-09-19 | Monsanto Company | Antifungal polypeptide and methods for controlling plant pathogenic fungi |
US6635740B1 (en) | 1997-03-27 | 2003-10-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Ligand/lytic peptide compositions and methods of use |
AU6587998A (en) * | 1997-03-27 | 1998-10-20 | Demeter Biotechnologies, Ltd. | Ligand/lytic peptide compositions and methods of use |
EP1878438B1 (fr) * | 1997-03-27 | 2017-11-29 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions de peptide ligand/lytique et procédés d'utilisation |
FR2766207B1 (fr) * | 1997-07-11 | 2000-12-08 | Rhone Poulenc Agrochimie | Gene chimere codant pour la drosomycine, vecteur le contenant pour la transformation des cellules vegetales et plantes transformees obtenues resistantes aux maladies |
FR2766206A1 (fr) * | 1997-07-11 | 1999-01-22 | Rhone Poulenc Agrochimie | Gene chimere codant pour la drosomycine, vecteur le contenant pour la transformation des cellules vegetales et plantes transformees obtenues resistantes aux maladies |
US6680058B1 (en) | 1997-09-03 | 2004-01-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions and methods for contraception in or sterilization of mammals |
KR19990081420A (ko) * | 1998-04-29 | 1999-11-15 | 성재갑 | 효모 2 하이브리드 시스템으로 검색할 수 있는 유비퀴틴을 이용한 펩타이드 라이브러리 및 그의 제조방법 |
US7087811B1 (en) | 1998-12-11 | 2006-08-08 | Agency For Science, Technology And Research | Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
US6875744B2 (en) | 2001-03-28 | 2005-04-05 | Helix Biomedix, Inc. | Short bioactive peptides |
JP4310107B2 (ja) * | 2001-03-28 | 2009-08-05 | ヘリックス バイオメディックス,インコーポレイテッド | 生物活性を有する短ペプチド及び該ペプチドの使用方法 |
DE10201862A1 (de) | 2002-01-18 | 2003-08-07 | Deutsches Krebsforsch | Konjugat zur Behandlung prokaryontischer Infektionen |
US20050034188A1 (en) * | 2002-03-20 | 2005-02-10 | J. R. Simplot Company | Refined plant transformation |
CA2479739C (fr) * | 2002-03-20 | 2013-02-19 | J.R. Simplot Company | Transformation raffinee des plantes |
CN1894277A (zh) * | 2003-02-24 | 2007-01-10 | 陶氏环球技术公司 | 周期性抗微生物肽 |
US7091185B2 (en) * | 2003-02-24 | 2006-08-15 | Dow Global Technologies Inc. | Periodic antimicrobial peptides |
EP1853620B1 (fr) | 2005-02-09 | 2012-01-11 | Helix Biomedix, Inc. | Hexapeptides antimicrobiens |
TW200700076A (en) * | 2005-03-18 | 2007-01-01 | Novozymes As | Polypeptides having antimicrobial activity and polynucleotides encoding same |
US7534762B2 (en) | 2005-03-18 | 2009-05-19 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
DK2252627T3 (en) | 2008-01-24 | 2017-08-14 | Esperance Pharmaceuticals | MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME. |
EP2168591A1 (fr) * | 2008-09-24 | 2010-03-31 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Peptides antimicrobiens |
JP2015532114A (ja) * | 2012-10-20 | 2015-11-09 | セルフダイアグノスティックス オーウー | 生物学的サンプル及び体液に由来する核酸標的の検出のための方法及びその組成物 |
WO2014070957A1 (fr) | 2012-10-30 | 2014-05-08 | Esperance Pharmaceuticals, Inc. | Conjugués anticorps/médicament et leurs procédés d'utilisation |
JP5918295B2 (ja) * | 2014-04-14 | 2016-05-18 | 佛教慈濟醫療財團法人大林慈濟醫院 | 融合蛋白質、その製造方法、及び融合蛋白質により抗原ペプチドを小胞体に輸送する方法 |
US10016480B2 (en) * | 2014-10-14 | 2018-07-10 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Peptide-based methods for treating pancreatic cancer |
CN107614004B (zh) * | 2015-03-23 | 2022-12-06 | 激流生物科学有限公司 | 抗微生物肽及其使用方法 |
US10413584B1 (en) | 2018-08-29 | 2019-09-17 | Riptide Bioscience, Inc. | Peptides having immunomodulatory properties |
US10548944B1 (en) | 2018-10-19 | 2020-02-04 | Riptide Bioscience, Inc. | Antimicrobial peptides and methods of using the same |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4520016A (en) | 1980-06-17 | 1985-05-28 | Kabigen Ab | Bacteriolytic proteins |
US4355104A (en) | 1980-06-17 | 1982-10-19 | Kabigen Ab | Bacteriolytic proteins |
WO1986004356A1 (fr) * | 1985-01-28 | 1986-07-31 | International Genetic Engineering, Inc. | PROMOTEURS D'araB ET PROCEDE DE PRODUCTION DE POLYPEPTIDES, Y COMPRIS DES CECROPINES, PAR DES TECHNIQUES MICROBIOLOGIQUES |
US5028530A (en) | 1985-01-28 | 1991-07-02 | Xoma Corporation | AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques |
US5196321A (en) | 1986-10-02 | 1993-03-23 | Massachusetts Institute Of Technology | Methods for in vitro cleavage of ubiquitin fusion proteins |
US5093242A (en) | 1986-10-02 | 1992-03-03 | Massachusetts Institute Of Technology | Methods of generating desired amino-terminal residues in proteins |
US5132213A (en) | 1986-10-02 | 1992-07-21 | Massachusetts Institute Of Technology | Method for producing proteins and polypeptides using ubiquitin fusions |
US4810777A (en) | 1987-03-04 | 1989-03-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antimicrobial compounds |
EP0675960A1 (fr) * | 1987-11-02 | 1995-10-11 | Louisiana State University and Agricultural and Mechanical College | Plantes ameliorees genetiquement pour resister aux maladies |
ES2060765T3 (es) * | 1988-05-17 | 1994-12-01 | Lubrizol Genetics Inc | Sistema promotor de ubiquitina en plantas. |
DE69034085T2 (de) * | 1989-04-10 | 2004-05-27 | Helix BioMedix, Inc., Bothell | Lytsche und proliferative Peptide und deren Verwendung als Pharmaka und Phytopharmaka |
CA2030779A1 (fr) * | 1989-04-11 | 1990-10-12 | Huw M. Davies | Utilisation de peptides antimicrobiens d'origine animale pour lutter contre les agents pathogenes des plantes |
US5620923A (en) * | 1989-10-12 | 1997-04-15 | The University Of Utah | Synthesis of peptides as cloned ubiquitin extensions |
US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
GB9127250D0 (en) | 1991-12-23 | 1992-02-19 | Unilever Plc | Modification |
DE69332740T2 (de) * | 1992-08-21 | 2004-02-05 | The University Of British Columbia, Vancouver | Kationische peptide und verfahren zu deren herstellung |
US5773705A (en) * | 1992-12-31 | 1998-06-30 | Wisconsin Alumni Research Foundation | Ubiquitin fusion protein system for protein production in plants |
GB9300281D0 (en) * | 1993-01-08 | 1993-03-03 | Zeneca Ltd | Antimicrobial-protein-producing endosymbiotic micro-organisms |
AU6290496A (en) * | 1995-06-27 | 1997-01-30 | Igen International, Inc. | High-level expression and efficient recovery of ubiquitin fusion proteins from escherichia coli |
-
1995
- 1995-07-23 IL IL11469795A patent/IL114697A0/xx unknown
- 1995-07-24 CA CA002195625A patent/CA2195625C/fr not_active Expired - Fee Related
- 1995-07-24 EP EP95928127A patent/EP0781347A4/fr not_active Withdrawn
- 1995-07-24 AU AU31996/95A patent/AU3199695A/en not_active Abandoned
- 1995-07-24 AU AU31995/95A patent/AU3199595A/en not_active Abandoned
- 1995-07-24 WO PCT/US1995/009338 patent/WO1996003522A1/fr active Application Filing
- 1995-07-24 WO PCT/US1995/009339 patent/WO1996003519A1/fr not_active Application Discontinuation
- 1995-07-24 JP JP8505918A patent/JPH10507069A/ja not_active Ceased
-
2000
- 2000-01-14 US US09/482,611 patent/US6448391B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0781347A4 (fr) | 2000-03-22 |
CA2195625A1 (fr) | 1996-02-08 |
US6448391B1 (en) | 2002-09-10 |
AU3199695A (en) | 1996-02-22 |
CA2195625C (fr) | 2000-10-10 |
JPH10507069A (ja) | 1998-07-14 |
WO1996003519A1 (fr) | 1996-02-08 |
EP0781347A1 (fr) | 1997-07-02 |
WO1996003522A1 (fr) | 1996-02-08 |
AU3199595A (en) | 1996-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL114697A0 (en) | Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use | |
PL320824A1 (en) | Aerodol form of a preparation of peptides and proteins | |
EP0785276A4 (fr) | Modification d'un peptide et d'une proteine | |
EP0799577A4 (fr) | Melange de peptides et leurs produits | |
IL113708A0 (en) | Protein production and protein delivery | |
HUP0000302A3 (en) | Ob fusion protein compositions and methods | |
EP0704532A3 (fr) | Protéines chimériques recombinantes et procédés pour leur utilisation | |
AU6428890A (en) | Therapeutic peptides and proteins | |
EP0939761A4 (fr) | Proteines secretees par la salmonelle et utilisations de ces proteines | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
ZA96240B (en) | Novel peptides their preparation and use | |
HU9502114D0 (en) | Expression system using autolysable fusion protein and new reducing polypeptides | |
SG52708A1 (en) | Chimeric receptor polypeptides human h13 proteins and uses thereof | |
IL116658A0 (en) | Peptides their preparation and use | |
IL110954A (en) | Pharmaceutical compositions comprising a retinoblastoma polypeptide or protein and methods for the preparation and use thereof | |
GB9423372D0 (en) | Proteins and their uses | |
IL114356A0 (en) | A human fibroblast derived protein and its preparation | |
GB2336844B (en) | Anti-hiv peptides and proteins | |
ZA983622B (en) | Protein composition preparation and use thereof and products containing same and preparation thereof | |
ZA978220B (en) | PTX-sensitive G proteins their preparation and use | |
EP0540575A4 (en) | Human meg-csf protein and methods | |
IL116976A0 (en) | Synthetic peptides and pharmaceutical compositions comprising them | |
EP0857732A4 (fr) | Proteine humaine analogue a la pec-60 et adn qui la code | |
AUPM832694A0 (en) | Peptides and polypeptides | |
IL112094A0 (en) | Novel peptides and pharmaceutical compositions comprising them |